Incremental Increases in glucocorticoid doses may reduce the risk of osmotic demyelination syndrome in a patient with hyponatremia due to central adrenal insufficiency

N/ACitations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

A 50-year-old man was admitted to our hospital because of general malaise. Laboratory tests revealed severe hyponatremia (104 mEq/L), which was attributed to central adrenal insufficiency. To treat presumed central diabetes insipidus (CDI), we administered a small dose of hydrocortisone and gradually increased it to maintenance doses to prevent osmotic demyelination syndrome (ODS). Serum sodium levels did not increase more than 10 mEq/L/day and ODS did not occur. Thereafter, the patient was proven to have CDI. Incremental increases in glucocorticoid dose may reduce the risk of ODS for patients with hyponatremia due to central adrenal insufficiency, especially that complicated by CDI. © 2012 The Japanese Society of Internal Medicine.

Cite

CITATION STYLE

APA

Yoshioka, K., Minami, M., Fujimoto, S., Yamaguchi, S., Adachi, K., & Yamagami, K. (2012). Incremental Increases in glucocorticoid doses may reduce the risk of osmotic demyelination syndrome in a patient with hyponatremia due to central adrenal insufficiency. Internal Medicine, 51(9), 1069–1072. https://doi.org/10.2169/internalmedicine.51.6507

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free